financetom
Business
financetom
/
Business
/
Clover Health Investments Insider Sold Shares Worth $722,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Clover Health Investments Insider Sold Shares Worth $722,000, According to a Recent SEC Filing
Mar 11, 2025 1:43 PM

04:20 PM EDT, 03/11/2025 (MT Newswires) -- Carladenise Armbrister Edwards, Director, on March 07, 2025, sold 200,000 shares in Clover Health Investments ( CLOV ) for $722,000. Following the Form 4 filing with the SEC, Edwards has control over a total of 273,227 Class A common shares of the company, with 273,227 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1801170/000180117025000068/xslF345X05/wk-form4_1741723964.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
European Commission official sees $100 billion in private chip investment by 2030
European Commission official sees $100 billion in private chip investment by 2030
May 22, 2024
ANTWERP, Belgium (Reuters) - The European Chips Act is on track to help attract more than 100 billion euros ($108.41 billion) worth of private investment to the European semiconductor industry by 2030, a European Commission official said on Wednesday. Thomas Skordas was speaking at a conference in Antwerp about the future of the initiative, which is Europe's answer to similar...
Congo lawyers say they have new evidence on Apple's minerals supply chain
Congo lawyers say they have new evidence on Apple's minerals supply chain
May 22, 2024
PARIS, May 22 (Reuters) - International lawyers representing the government of the Democratic Republic of Congo said on Wednesday they had new evidence gathered from whistleblowers, which deepened concerns that Apple ( AAPL ) could be sourcing minerals from conflict areas in eastern Congo. In a statement, the lawyers urged Apple ( AAPL ) to answer questions about its supply...
G1 Therapeutics Grants Deimos Biosciences License to Market Anti-Radiation Treatment -- Shares Up Pre-Bell
G1 Therapeutics Grants Deimos Biosciences License to Market Anti-Radiation Treatment -- Shares Up Pre-Bell
May 22, 2024
07:17 AM EDT, 05/22/2024 (MT Newswires) -- G1 Therapeutics ( GTHX ) and Jupiter Bioventures' Deimos Biosciences said Wednesday they have entered a global licensing agreement for lerociclib to treat radiation exposure. Lerociclib is a selective inhibitor of cyclin-dependent kinases 4 and 6, which can increase the survival of animals exposed to radiation, the companies said. The deal grants Deimos...
US consumer watchdog will apply credit card rules to buy now, pay later companies
US consumer watchdog will apply credit card rules to buy now, pay later companies
May 22, 2024
(Reuters) - The U.S. Consumer Financial Protection Bureau will apply some credit card consumer protection rules to buy now, pay later (BNPL) lenders, the agency said on Wednesday, in a bid to impose more oversight on the fast-growing sector. BNPL providers such as Affirm, Klarna and Afterpay partner with retailers to finance customer purchases, which shoppers repay in installments. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved